Niagen Bioscience
NAGE
48 hedge funds and large institutions have $16.5M invested in Niagen Bioscience in 2016 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
10.53% more ownership
Funds ownership: 0% → 10.53% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.28M |
| 2 |
BlackRock Fund Advisors
San Francisco,
California
|
+$3.52M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.38M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.04M |
| 5 |
BlackRock Institutional Trust
San Francisco,
California
|
+$952K |
Top Sellers
NAGE Hedge Fund Activity: Q2 2016 in Review
48 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2016, worth a combined $16.5M.
Buyers outnumbered sellers: 48 funds opened new NAGE positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $4.28M.
- 48 institutional investors held Niagen Bioscience (NAGE) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $16.5M of Niagen Bioscience stock for Q2 2016.
- 48 funds opened new Niagen Bioscience positions in Q2 2016 and 0 closed out, a net change of +48 holders.
- The largest Niagen Bioscience buyer in Q2 2016 was Vanguard Group, an estimated $4.28M added.
Based on aggregated 13F filings for Q2 2016.